ConductScience.org, home

Paper29037232

A systematic investigation of the maximum tolerated dose of cytotoxic chemotherapy with and without supportive care in mice.

Aston WJ and 5 others. BMC Cancer, 2017. Cited by 153 papers, by iCite.

Cite this record

ConductScience Library. A systematic investigation of the maximum tolerated dose of cytotoxic chemotherapy with and without supportive care in mice. Papers, record 29037232. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29037232

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A systematic investigation of the maximum tolerated dose of cytotoxic chemotherapy with and without supportive care in mice.
PubMed
Journal
BMC Cancer
PubMed
Year
2017
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
153
iCite
Relative citation ratio, by iCite
5.75
iCite
Revised in PubMed
2018-11-13
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Aston WJWayne J
2Hope DEDanika E
3Nowak AKAnna K
4Robinson BWBruce W
5Lake RARichard A
6Lesterhuis WJW Joost

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic Combined Chemotherapy ProtocolsMajor topic
EtoposideMajor topic
Maximum Tolerated DoseMajor topic
NeoplasmsMajor topic
Animals
Disease Models, Animal
Dose-Response Relationship, Drug
Humans
Mice

Source PubMed

Download CSV of topics

References83

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
118695136Antitumor effects of doxorubicin followed by zoledronic acid in a mouse model of breast cancer.J Natl Cancer Inst2008https://conductscience.org/library/papers/18695136PubMed
226188166Ondansetron attenuates co-morbid depression and anxiety associated with obesity by inhibiting the biochemical alterations and improving serotonergic neurotransmission.Pharmacol Biochem Behav2015https://conductscience.org/library/papers/26188166PubMed
310658523Cisplatin (P), vinblastine (V) and bleomycin (B) combination chemotherapy in recurrent or advanced granulosa(-theca) cell tumours of the ovary. An EORTC Gynaecological Cancer Cooperative Group study.Eur J Cancer1999https://conductscience.org/library/papers/10658523PubMed
424184695The cellular mechanisms of the antiemetic action of dexamethasone and related glucocorticoids against vomiting.Eur J Pharmacol2014https://conductscience.org/library/papers/24184695PubMed
526968813In vitro and in vivo effects of a recombinant anti-PSMA immunotoxin in combination with docetaxel against prostate cancer.Oncotarget2016https://conductscience.org/library/papers/26968813PubMed
610458234Allogeneic bone marrow transplantation versus chemotherapy for the treatment of childhood acute lymphoblastic leukemia in second remission: a single-institution study.J Clin Oncol1999https://conductscience.org/library/papers/10458234PubMed
712802024Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease.N Engl J Med2003https://conductscience.org/library/papers/12802024PubMed
826724433Chemotherapy and immunotherapy: mapping the road ahead.Curr Opin Immunol2016https://conductscience.org/library/papers/26724433PubMed
921383056Contribution of IL-17-producing gamma delta T cells to the efficacy of anticancer chemotherapy.J Exp Med2011https://conductscience.org/library/papers/21383056PubMed
1015899580Cyclophosphamide decreases the number, percentage and the function of CD25+ CD4+ regulatory T cells, which suppress induction of contact hypersensitivity.J Dermatol Sci2005https://conductscience.org/library/papers/15899580PubMed
1124259502Etoposide selectively ablates activated T cells to control the immunoregulatory disorder hemophagocytic lymphohistiocytosis.J Immunol2014https://conductscience.org/library/papers/24259502PubMed
1218540827Immune-potentiating effects of the chemotherapeutic drug cyclophosphamide.Crit Rev Immunol2008https://conductscience.org/library/papers/18540827PubMed
1389906Effects of systemically administered bleomycin or adriamycin with local hyperthermia on primary tumor and lung metastases.Cancer Treat Rep1979https://conductscience.org/library/papers/89906PubMed
1422001253Effects of multiple doses of cyclophosphamide on mouse testes: accessing the germ cells lost, and the functional damage of stem cells.Reprod Toxicol2011https://conductscience.org/library/papers/22001253PubMed
1521765211Platinum-based drugs disrupt STAT6-mediated suppression of immune responses against cancer in humans and mice.J Clin Invest2011https://conductscience.org/library/papers/21765211PubMed
166387060The importance of dose intensity in chemotherapy of metastatic breast cancer.J Clin Oncol1984https://conductscience.org/library/papers/6387060PubMed
179815644Docetaxel enhances tumor radioresponse in vivo.Clin Cancer Res1997https://conductscience.org/library/papers/9815644PubMed
1819436029Dose escalation methods in phase I cancer clinical trials.J Natl Cancer Inst2009https://conductscience.org/library/papers/19436029PubMed
199554586Preclinical in vivo antitumor activity of vinflunine, a novel fluorinated Vinca alkaloid.Cancer Chemother Pharmacol1998https://conductscience.org/library/papers/9554586PubMed
209500186Oral versus intraperitoneal administration of irinotecan in the treatment of human neuroblastoma in nude mice.Cancer Lett1998https://conductscience.org/library/papers/9500186PubMed

See all 83 referencesDownload CSV of references

Cited by104

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 153 citations.

PMIDTitleJournalYearIn PapersSource
42861467Preclinical Pharmacokinetic-Pharmacodynamic Modeling of Antibody Nanoconjugates for Breast Cancer Treatment.CPT Pharmacometrics Syst Pharmacol2026https://conductscience.org/library/papers/42861467PubMed
42573677A novel tetrahydrocurcumin derivative as a potential anti-colorectal cancer agent: studies on its design, synthesis, and in vitro and in vivo biological evaluation.Nat Prod Bioprospect2026https://conductscience.org/library/papers/42573677PubMed
42503515Bacteria-mimicking cancer cells reprogram macrophages via multiple pattern recognition receptor pathways for cancer immunotherapy.Signal Transduct Target Ther2026https://conductscience.org/library/papers/42503515PubMed
42454521Differential impact of cancer- and chemotherapy-induced cachexia: a comparative analysis in a preclinical model of colorectal cancer by biological sex.Am J Physiol Endocrinol Metab2026https://conductscience.org/library/papers/42454521PubMed
42384606In Silico Drug Repositioning Identifies SYK Kinase Inhibitors as Potential Neuroprotective Agents for Ataxia-Telangiectasia.Chem Biol Drug Des2026https://conductscience.org/library/papers/42384606PubMed
42376386Determination of the optimal cisplatin dose to induce anemia in streptozotocin-nicotinamide-induced type 2 diabetic rats: A preliminary study.Open Vet J2026https://conductscience.org/library/papers/42376386PubMed
42099027Evaluation of Arabica coffee pulp extract on sperm quality and hematology in cyclophosphamide-treated rats.Environ Anal Health Toxicol2026https://conductscience.org/library/papers/42099027PubMed
41824583Microrobotic copper-rich electrochemical interfacing for targeted cancer theranostics in the gut.Sci Adv2026https://conductscience.org/library/papers/41824583PubMed
41549226All-PEG-Like Block Copolymers Self-Assemble into Stealth Nanocarriers for Drug Delivery.Adv Sci (Weinh)2026https://conductscience.org/library/papers/41549226PubMed
41547980Influences of formulations and administration routes on docetaxel tissue distribution in mice.Sci Rep2026https://conductscience.org/library/papers/41547980PubMed
41451844Loss-of-function genetic screen unveils synergistic efficacy of PARG inhibition with combined 5-fluorouracil and irinotecan treatment in colorectal cancer.Clin Transl Med2025https://conductscience.org/library/papers/41451844PubMed
41350954Enhanced Efficacy and Safety: Cabazitaxel Nanodispersions as a Novel Therapeutic Platform against Prostate Cancer.AAPS PharmSciTech2025https://conductscience.org/library/papers/41350954PubMed
41346803Leveraging topoisomerase II-mediated DNA damage: repurposing etoposide as a lead compound for apicomplexan parasite control.Front Vet Sci2025https://conductscience.org/library/papers/41346803PubMed
41186408Optogenetic Cancer Therapy Using the Light-Driven Outward Proton Pump Rhodopsin Archaerhodopsin-3 (AR3).J Am Chem Soc2025https://conductscience.org/library/papers/41186408PubMed
41154612The Convergence of Biology and Material Science: Biomolecule-Driven Smart Drug Delivery Systems.Biomolecules2025https://conductscience.org/library/papers/41154612PubMed
41148819The Immunomodulatory Role of Gemcitabine in Triple Negative Breast Cancer.Cells2025https://conductscience.org/library/papers/41148819PubMed
40940745Doxorubicin-Loaded Nanoparticle Treatment Enhances Diffuse Large B-Cell Lymphoma Cell Death.Cells2025https://conductscience.org/library/papers/40940745PubMed
40792484Three Is Better than One: A Multimetal Complex that Triggers Immunogenic Cell Death.Angew Chem Int Ed Engl2025https://conductscience.org/library/papers/40792484PubMed
40751101Chemotherapy alters radiosensitivity and GRPR expression of prostate and breast cancer cells.EJNMMI Res2025https://conductscience.org/library/papers/40751101PubMed
40708972Synergistic drug combination screening using a nanodroplet processing platform to enhance neuroblastoma treatment in TH-MYCN transgenic mice.Bioeng Transl Med2025https://conductscience.org/library/papers/40708972PubMed

See all 104 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
IL17A3605PubTator's text mininghttps://conductscience.org/library/genes/3605

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29037232

GET https://conductscience.org/api/papers/v1/29037232/references?page=2